Similar articles

• [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].

  Magnusson C, Reeves G. Magnusson C, et al. Lakartidningen. 2005 Apr 18-24;102(16):1228-30. Lakartidningen. 2005. PMID: 15921095 Swedish. No abstract available.
• ["Menopause medicine" a growing discipline. Many questions on hormones and women's health are still unanswered].

  von Schoultz B. von Schoultz B. Lakartidningen. 2001 Jan 31;98(5):412-6. Lakartidningen. 2001. PMID: 11229081 Review. Swedish. No abstract available.
• A personal initiative for women's health: to challenge the Women's Health Initiative.

  Genazzani AR, Gambacciani M. Genazzani AR, et al. Gynecol Endocrinol. 2002 Aug;16(4):255-7. Gynecol Endocrinol. 2002. PMID: 12396552 No abstract available.
• [The SBU revises its view on estrogen replacement therapy in climacteric. Evidently increased risk of thrombosis and breast cancer].

  Hovelius B. Hovelius B. Lakartidningen. 2002 Jul 11;99(28-29):3014-5. Lakartidningen. 2002. PMID: 12170508 Swedish. No abstract available.
• [Is estrogen replacement therapy increasing or decreasing the risk of cancer?].

  Auranen A, Grénman S, Anttila L, Salmi T. Auranen A, et al. Duodecim. 2003;119(22):2199-206. Duodecim. 2003. PMID: 14702809 Review. Finnish. No abstract available.